{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:36:57Z","timestamp":1774571817771,"version":"3.50.1"},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,12,1]]},"DOI":"10.2169\/internalmedicine.9439-22","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T22:11:25Z","timestamp":1651875085000},"page":"3585-3588","source":"Crossref","is-referenced-by-count":5,"title":["FLAMES with Elevated Myelin Basic Protein Followed by Myelitis"],"prefix":"10.2169","volume":"61","author":[{"given":"Hiroyuki","family":"Hokama","sequence":"first","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Nippon Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Nippon Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Nippon Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seira","family":"Hatake","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Nippon Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuho","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Nippon Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroto","family":"Kodera","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Nippon Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihito","family":"Kutsuna","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Nippon Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikako","family":"Nito","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Nippon Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunya","family":"Nakane","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Nippon Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Nagayama","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Nippon Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tohoku University Graduate School of Medicine, Japan"},{"name":"Department of Neurology, National Hospital Organization Yonezawa National Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Nippon Medical School, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Sato DK, Callegaro D, Lana-Peixoto MA, et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 82: 474-481, 2014.","DOI":"10.1212\/WNL.0000000000000101"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ogawa R, Nakashima I, Takahashi T, et al. MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy. Neurol Neuroimmunol Neuroinflamm 4: e322, 2017.","DOI":"10.1212\/NXI.0000000000000322"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Budhram A, Mirian A, Le C, Hosseini-Moghaddam SM, Sharma M, Nicolle MW. Unilateral cortical FLAIR-hyperintense lesions in anti-MOG-associated encephalitis with seizures (FLAMES): characterization of a distinct clinico-radiographic syndrome. J Neurol 266: 2481-2487, 2019.","DOI":"10.1007\/s00415-019-09440-8"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Numa S, Kasai T, Kondo T, et al. An adult case of anti-myelin oligodendrocyte glycoprotein (MOG) antibody-associated multiphasic acute disseminated encephalomyelitis at 33-year intervals. Intern Med 55: 699-702, 2016.","DOI":"10.2169\/internalmedicine.55.5727"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Yamamoto D, Uchiyama T, Ohashi T, Iizuka T. Case of steroid-responsive unilateral encephalitis with anti-myelin oligodendrocyte glycoprotein antibodies. Neurol Clin Neurosci 5: 101-102, 2017.","DOI":"10.1111\/ncn3.12119"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Sugimoto T, Ishibashi H, Hayashi M, et al. A case of anti-MOG antibody-positive unilaterally dominant meningoencephalitis followed by longitudinally extensive transverse myelitis. Mult Scler Relat Disord 25: 128-130, 2018.","DOI":"10.1016\/j.msard.2018.07.028"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Fujimori J, Takai Y, Nakashima I, et al. Bilateral frontal cortex encephalitis and paraparesis in a patient with anti-MOG antibodies. J Neurol Neurosurg Psychiatry 88: 534-536, 2017.","DOI":"10.1136\/jnnp-2016-315094"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Wang L, ZhangBao J, Zhou L, et al. Encephalitis is an important clinical component of myelin oligodendrocyte glycoprotein antibody associated demyelination: a single-center cohort study in Shanghai, China. Eur J Neurol 26: 168-174, 2019.","DOI":"10.1111\/ene.13790"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ramanathan S, Mohammad S, Tantsis E, et al. Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination. J Neurol Neurosurg Psychiatry 89: 127-137, 2018.","DOI":"10.1136\/jnnp-2017-316880"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kaneko K, Sato DK, Nakashima I, et al. Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies. J Neurol Neurosurg Psychiatry 87: 1257-1259, 2016.","DOI":"10.1136\/jnnp-2015-312676"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Russ JB, Timbie CM, Li Y, Gonzalez-Giraldo E. Clinical reasoning: an 11-year-old girl with focal seizures, fevers, and unilateral, enhancing cortical lesions. Neurology 95: e3153-e3159, 2020.","DOI":"10.1212\/WNL.0000000000010655"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Spadaro M, Winklmeier S, Beltran E, et al. Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein. Ann Neurol 84: 315-328, 2018.","DOI":"10.1002\/ana.25291"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ikeda T, Yamada K, Ogawa R, et al. The pathological features of MOG antibody-positive cerebral cortical encephalitis as a new spectrum associated with MOG antibodies: a case report. J Neurol Sci 392: 113-115, 2018.","DOI":"10.1016\/j.jns.2018.06.028"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. van der Valk P, De Groot CJ. Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS. Neuropathol Appl Neurobiol 26: 2-10, 2000.","DOI":"10.1046\/j.1365-2990.2000.00217.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Levin SD, Hoyle NR, Brown JK, Thomas DG. Cerebrospinal fluid myelin basic protein immunoreactivity as an indicator of brain damage in children. Dev Med Child Neurol 27: 807-813, 1985.","DOI":"10.1111\/j.1469-8749.1985.tb03806.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/23\/61_9439-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:30:52Z","timestamp":1715315452000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/23\/61_9439-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":15,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9439-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]},"article-number":"9439-22"}}